HbOT provides endometriosis patients an alternative and complement to other conventional therapies.
- Hyperbaric oxygen therapy (HbOT), according to studies, provides endometriosis patients a potential alternative and complement to other, conventional, therapies.
- In 2010, the Journal of Reproductive Medicine published promising findings about HbOT for Endometriosis, highlighting its potential benefits, especially for women with endometriosis-related infertility.
- HbOT is drug and intervention free, and some sufferers have found huge success with it.
- Overall, the prospective advantages of HbOT for Endometriosis are encouraging. More studies are required to completely realise it’s potential as a remedy for this ailment.
- We do not recommend Hyperbaric oxygen Therapy as a replacement for conventional treatments, if you are unsure please consult your doctor.
Can HbOT help with Endometriosis?
One in ten women who are reproductive-age suffer from the gynaecological condition endometriosis. It is characterised by endometrial tissue growing outside of the uterus, which can result in infertility, persistent pelvic discomfort, and other symptoms. Despite the fact that there are several endometriosis treatment options, some people may not respond well to these treatments. Hyperbaric oxygen therapy (HBOT), according to studies, may provide endometriosis patients a potential alternative to other conventional therapies.
HBOT involves the patient breathing pure oxygen a higher-than-normal atmospheric pressure. In this environment blood can dissolve more oxygen, improving the blood’s ability to carry oxygen to tissues and fostering healing. HBOT has been used for many years to treat a range of illnesses, such as burns, wounds, and carbon monoxide poisoning. Studies into its possible advantages for endometriosis, whilst still at an early stage are proving very promising.
The effects of HBOT on women who have persistent pelvic pain due to endometriosis were investigated in a 2012 research that appeared in the Journal of Obstetrics and Gynaecology Research. 33 people took part in the trial, and over the course of four weeks, they each received 20 HBOT sessions. The individuals’ pain levels and quality of life scores were significantly improved following the treatment period, according to the researchers’ findings. Also, the researchers saw a considerable decline in pelvic inflammation as indicated by blood levels of inflammatory markers.
A further investigation on the effects of HBOT in women with endometriosis-related infertility was published in the Journal of Reproductive Medicine in 2010. During the course of two months, 20 individuals in the research underwent 40 HBOT sessions. The individuals’ fertility significantly improved following the treatment period, the researchers discovered, with a 40% pregnancy rate among those who finished the trial. Further evidence that HBOT may improve ovarian function came from the researchers’ observations of a substantial decrease in pelvic inflammation and an increase in the number of ovarian follicles.
The capacity of HBOT to lower inflammation and encourage healing may be associated with its potential advantages for endometriosis. Chronic pelvic inflammation, a feature of endometriosis, can aggravate discomfort, infertility, and other symptoms. As a result of the body producing more anti-inflammatory cytokines and expressing less pro-inflammatory cytokines, HBOT has been demonstrated to decrease inflammation. Furthermore, HBOT for Endometriosis can enhance tissue oxygenation and encourage the development of new blood vessels, which could enhance tissue regeneration and repair.